COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,837 Articles (22,553 medRxiv, 8,284 bioRxiv)

Most recent first Previous |  Page 1236: Articles 12351-12360  | Next

Socioeconomic and comorbid factors affecting mortality and length of stay in COVID-19
Delora, A., Mills, A., Jacobson, D., Cornett, B., Peacock, W. F., Datta, A., Jenks, S.
10.1101/2021.08.26.21262693 — Posted: 2021-08-28
History of suicide attempts and COVID-19 infection in Veterans with schizophrenia or schizoaffective disorder: effect modification by age and obesity
Okusaga, O. O., Kember, R. L., Peloso, G. M., Peterson, R. E., Vujkovic, M., Mitchell, B. G., Bernard, J., Walder, A., Bigdeli, T. B.
10.1101/2021.08.25.21262627 — Posted: 2021-08-28
Mental health and substance use associated with hospitalization among people with laboratory confirmed diagnosis of COVID-19 in British Columbia: a population-based cohort study
Velasquez Garcia, H. A., Wilton, J., Smolina, K., Chong, M., Rasali, D., Otterstatter, M., Rose, C., Prystajecky, N., David, S., Galanis, E., McKee, G., Krajden, M., Janjua, N. Z.
10.1101/2021.08.26.21262697 — Posted: 2021-08-28
Effectiveness of the WHO-authorized Covid-19 Vaccines: a Rapid Review of Global Reports till June 30, 2021
Cheng, C.-J., Lu, C.-Y., Chang, Y.-H., Sun, Y., Chu, H.-J., Lee, C.-Y., Liu, C.-H., Lin, C.-H., Lu, C.-J., Li, C.-Y.
10.1101/2021.08.23.21262500 — Posted: 2021-08-28
Effect of losartan on hospitalized patients with COVID-19-induced lung injury: A randomized clinical trial
Puskarich, M. A., Ingraham, N. E., Merck, L. H., Driver, B. E., Wacker, D. A., Black, L. P., Jones, A. E., Fletcher, C. V., South, A. M., Nelson, A. C., Murray, T. A., Lewandowski, C., Farhat, J., Benoit, J. L., Bryne, D., Hall, A., Reilkoff, R. A., Biros, M. H., Cherabuddi, K., Chipman, J. G., Schacker, T. W., Bold, T., Beckman, K. B., Langlois, R., Aliota, M., Guirgis, F., Galbraith, J., Beyer, M., Salmen, C., Roberts, B. W., Wright, D. W., Voelker, H., Koopmeiners, J. S., Tignanelli, C. J.
10.1101/2021.08.25.21262623 — Posted: 2021-08-28 Discussion: Onsite
Erytra Blood Group Analyser and Kode Technology testing of SARS-CoV-2 antibodies among convalescent patients and vaccinated individuals
Weinstock, C., Flegel, W. A., Srivastava, K., Kaiser, S., Schrezenmeier, H., Tsamadou, C., Ludwig, C., Jahrsdoerfer, B., Bovin, N. V., Henry, S. M.
10.1101/2021.08.26.21262219 — Posted: 2021-08-28
A Learning Health System Approach to the COVID-19 Pandemic: System-Wide Changes in Clinical Practice and 30-Day Mortality Among Hospitalized Patients
McCreary, E. J., Kip, K. E., Bariola, J. R., Schmidhofer, M., Minnier, T., Mayak, K., Albin, D., Daley, J., Linstrum, K., Hernandez, E., Sackrowitz, R., Hughes, K., Horvat, C., Snyder, G. M., McVerry, B. J., Yealy, D. M., Huang, D. T., Angus, D. C., Marroquin, O. C.
10.1101/2021.08.26.21262661 — Posted: 2021-08-28
When do we need massive computations to perform detailed COVID-19 simulations?
Lutz, C. B., Giabbanelli, P. J.
10.1101/2021.08.26.21262694 — Posted: 2021-08-28
Predicted long-term impact of COVID-19 pandemic-related care delays on cancer incidence and mortality in Canada
Malagon, T., Yong, J. H. E., Tope, P., Miller, W. H., Franco, E. L., McGill Task Force on the Impact of COVID-19 on Cancer Control and Care
10.1101/2021.08.26.21261149 — Posted: 2021-08-28
Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous?-A retrospective cohort study
Sirohiya, P., Elavarasi, A., Sagiraju, H. K. R., Baruah, M., Gupta, N., Kumar, R., Paul, S. S., Ratre, B. K., Singh, R., Kumar, B., Vig, S., Pandit, A., Kumar, A., Garg, R., Meena, V. P., Mittal, S., Pahuja, S., Das, N., Dwivedi, T., Gupta, R., Kumar, S., Pandey, M., Mishra, A., Matharoo, K. S., Mohan, A., Guleria, R., Bhatnagar, S.
10.1101/2021.08.26.21262668 — Posted: 2021-08-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).